Literature DB >> 31388267

Polyneuropathy Associated with Severe Iron Overload and Oxidative Stress in β-Thalassemia Patients.

Mona H El-Tagui1, Khaled M Salama1, Mohamed H El-Sabbagh2, Eman R Youness3, Marwa Ragaey2, Amina Abdel-Salam1.   

Abstract

To investigate the frequency of peripheral neuropathy in patients with β-thalassemia, and to assess its relation to iron overload and oxidative stress. Sixty β-thalassemia patients with mean age of 19 ± 4.9 years were recruited. Serum ferritin was quantitatively assessed by enzyme-linked immunoassay and biomarkers of oxidative stress were estimated calorimetrically. Electrophysiological studies using NEMUS 2, Galileu Software were carried out. The patients were separated into two groups: those with abnormal nerve conduction studies (NCS) {Group A; N = 38} and those with normal NCS {Group B; N = 22}. Thirty-eight (63.3%) patients had axonal motor neuropathy as evidenced by abnormal NCS (group A), they showed higher mean serum ferritin (p < 0.01), higher mean malondialdehyde (MDA) (p < 0.01), and lower mean nitrous oxide, total antioxidant capacity, paraoxonase-1 (PON1) (p < 0.01) compared to group B. Bivariate analysis of NCS data demonstrated that abnormal NCS were more frequent in splenectomized patients (p = 0.002), and poorly-chelated patients with serum ferritin ≥ 2000 ng/ml (p = 0.001). Significant variables associated with abnormal motor NCS were entered in stepwise regression analysis and only elevated serum ferritin (p = 0.01) was independently associated with abnormal motor NCS (p = 0.02; 95% CI 1.433-51.791). None of the studied patients had sensory neuropathy or myopathy. Peripheral motor neuropathy may occur in β-thalassemia patients at a high frequency, regardless of their age and gender. Severe iron overload may contribute to the pathogenesis of neuropathy. Other factors including chelation therapy, splenectomy, and oxidative stress might have an enhancing effect that couldn't be proved in this study.

Entities:  

Keywords:  Iron overload; Oxidative stress-β-Thalassemia; Polyneuropathy

Year:  2018        PMID: 31388267      PMCID: PMC6646492          DOI: 10.1007/s12288-018-1050-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  19 in total

1.  Axonal sensorimotor neuropathy in patients with beta-thalassaemia.

Authors:  E Stamboulis; N Vlachou; M Drossou-Servou; P Tsaftaridis; G Koutsis; N Katsaros; E Economou-Petersen; A Loutradi-Anagnostou
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

Review 2.  Uric acid and oxidative stress.

Authors:  G K Glantzounis; E C Tsimoyiannis; A M Kappas; D A Galaris
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Peripheral neuropathy in patients with beta-thalassaemia.

Authors:  D A Papanastasiou; D Papanicolaou; A M Magiakou; N G Beratis; E Tzebelikos; T Papapetropoulos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

4.  Neurophysiologic and intellectual evaluation of beta-thalassemia patients.

Authors:  Marina Economou; Dimitrios I Zafeiriou; Eleftherios Kontopoulos; Nikos Gompakis; Aphroditi Koussi; Vasilios Perifanis; Miranda Athanassiou-Metaxa
Journal:  Brain Dev       Date:  2005-05-31       Impact factor: 1.961

Review 5.  Neurological complications in beta-thalassemia.

Authors:  Dimitrios I Zafeiriou; Marina Economou; Miranta Athanasiou-Metaxa
Journal:  Brain Dev       Date:  2006-03-29       Impact factor: 1.961

6.  Effect of iron and lipid peroxidation on development of cerebellar granule cells in vitro.

Authors:  Y M Pu; Q Wang; Z M Qian
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

7.  Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.

Authors:  Rahul Naithani; Jagdish Chandra; Jayashree Bhattacharjee; Priyanka Verma; Shashi Narayan
Journal:  Pediatr Blood Cancer       Date:  2006-06       Impact factor: 3.167

Review 8.  Neuroprotection by flavonoids.

Authors:  F Dajas; F Rivera-Megret; F Blasina; F Arredondo; J A Abin-Carriquiry; G Costa; C Echeverry; L Lafon; H Heizen; M Ferreira; A Morquio
Journal:  Braz J Med Biol Res       Date:  2003-11-17       Impact factor: 2.590

Review 9.  C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects.

Authors:  Ch Romay; R González; N Ledón; D Remirez; V Rimbau
Journal:  Curr Protein Pept Sci       Date:  2003-06       Impact factor: 3.272

10.  Peripheral neuropathy in thalassaemia.

Authors:  Raja A Sawaya; Laila Zahed; Ali Taher
Journal:  Ann Saudi Med       Date:  2006 Sep-Oct       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.